0001415889-24-002828.txt : 20240206 0001415889-24-002828.hdr.sgml : 20240206 20240206170010 ACCESSION NUMBER: 0001415889-24-002828 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240202 FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Siatis Perry C CENTRAL INDEX KEY: 0001951400 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 24601040 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 form4-02062024_050202.xml X0508 4 2024-02-02 0001551152 AbbVie Inc. ABBV 0001951400 Siatis Perry C 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 false true false false EVP, GC AND SECRETARY 1 Common Stock, $0.01 par value 2024-02-02 4 A 0 2919 144.54 A 13296 D Common Stock, $0.01 par value 2024-02-02 4 D 0 2919 170 D 10377 D Option (Right to buy) 144.54 2024-02-02 4 M 0 2919 144.54 D 2023-02-17 2032-02-16 Common Stock 2919 5837 D This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on February 14, 2023. Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. T.O. Odutayo, attorney-in-fact for Perry C. Siatis 2024-02-06